Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate

Trade Name: 
Stribild
Manufacturer/Distributor: 
Gilead Sciences Canada
www.gilead.ca
Classification: 
Antiretroviral agent
ATC Class: 
J05AR - Antivirals for treatment of HIV, combinations
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2012/11/26
Date Marketed in Canada (yyyy/mm/dd): 
2012/12/20
Presentation: 
Tablet: combination. DIN: 02397137
Comments: 
Product contains per tablet: elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg (equivalent to 245 mg tenofovir disoproxil). Stribild is indicated as a complete regimen for HIV-1 infection in antiretroviral-naive adult patients 18 years and older.